Feb 26, 2026 07:00AM
Feb 11, 2026 07:00AM
Jan 23, 2026 09:00AM
Jan 23, 2026 09:00AM
Jan 12, 2026 07:04AM
Jan 12, 2026 07:00AM
Dec 12, 2025 07:00AM BioCryst receives FDA approval for ORLADEYO oral pellets for children
Dec 12, 2025 07:00AM
Nov 16, 2025 03:00PM
Nov 12, 2025 08:00AM
Nov 6, 2025 08:00AM
Nov 6, 2025 08:00AM
Nov 3, 2025 07:00AM
Oct 23, 2025 07:00AM BioCryst to Present New Pediatric HAE Data at the American College of Allergy, Asthma & Immunology 2025 Annual Scientific Meeting
Oct 14, 2025 07:00AM
Oct 14, 2025 07:00AM
Sep 11, 2025 08:18AM
Aug 11, 2025 07:02AM
Aug 11, 2025 07:00AM
Aug 4, 2025 07:00AM
Jul 31, 2025 07:00AM BioCryst names Charlie Gayer as next CEO after Jon Stonehouse retires
Jul 31, 2025 07:00AM
Jul 9, 2025 07:00AM
Jul 7, 2025 07:01AM
Jul 7, 2025 07:00AM
Jun 16, 2025 07:02AM
Jun 16, 2025 07:00AM
Jun 13, 2025 07:00AM BioCryst Pharma (BCRX): ORLADEYO Approved in Colombia
Jun 13, 2025 07:00AM
Jun 6, 2025 07:00AM
Jun 6, 2025 07:00AM
Jun 2, 2025 07:00AM
May 30, 2025 07:01AM
May 30, 2025 07:00AM
May 16, 2025 07:01AM BioCryst Pharma (BCRX) Presents New Real-world Evidence Showing Significant and Sustained Reductions in HAE Attack Rates in Adolescents and People with Severe HAE Following Initiation of ORLADEYO
May 16, 2025 07:00AM
May 14, 2025 07:00AM
May 6, 2025 09:43AM
May 5, 2025 07:00AM
May 1, 2025 07:02AM
May 1, 2025 07:00AM
Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets
Feb 24, 2025 07:00AM
Feb 24, 2025 06:00AM
Feb 12, 2025 07:01AM
Feb 12, 2025 07:00AM
Feb 10, 2025 08:33AM
Feb 10, 2025 08:30AM
Jan 10, 2025 07:01AM BioCryst Pharma (BCRX) Announces Preliminary Full Year 2024 ORLADEYO® (berotralstat) Net Revenue of $437
Jan 10, 2025 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All